Barclays analyst Lauren Lieberman raised the firm’s price target on Clorox (CLX) to $140 from $130 and keeps an Underweight rating on the shares. The company’s enterprise resource planning implementation should drive margin growth, but sales growth “remains an open question and will be for some time,” the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX:
